Breakthrough in Cancer Treatment: Novel Nanoparticles Show Efficacy in Targeting Cancer Stem Cells and Tumor-Associated Macrophages

Strategic Insights -

Researchers at Taiyuan University of Technology have made a significant breakthrough in the fight against cancer, developing a novel nanoparticle system that targets cancer stem cells and tumor-associated macrophages to promote immunotherapeutic efficacy. According to a study published in Colloids and Surfaces B-biointerfaces, the team successfully synthesized a mannose, polyethylene glycol, and polyethyleneimine modified graphene oxide based LDN193189-delivery system (PGPML) that can remodel the tumor microenvironment (TME) by inhibiting proliferation, migration, and epithelial-mesenchymal transition.

Key Takeaways:

  • The PGPML nanoparticles possess the capability to target cancer stem cells and M2 tumor-associated macrophages (TAMs) through specific binding to different mannose receptors, demonstrating a synergistic treatment approach combining cancer stem cell-targeted therapy with immunotherapy.
  • The PGPML nanoparticles significantly downregulate the expression of cancer stem cell marker CD133, attenuate PD-L1 expression within TME, and reduce tumor stemness characteristics, promoting T cell activation and macrophage M2-M1 repolarization to remodel TME.
  • The research showed that the PGPML nanoparticles can inhibit proliferation, migration, and epithelial-mesenchymal transition, efficiently displayed anti-tumor efficacy in vitro and in vivo.
  • The team found that the PGPML nanoparticles can enhance the levels of reactive oxygen species (ROS) and tumor necrosis factor-alpha (TNF-alpha) in tumor cells, fostering tumor cell demise.
  • The study's findings suggest that a synergistic treatment approach combining cancer stem cell-targeted therapy with immunotherapy holds promise as a potential therapeutic strategy for hepatocellular carcinoma (HCC).

Statistics:

  • The PGPML nanoparticles have a diameter of approximately 50 nanometers, allowing for efficient targeting of cancer stem cells and tumor-associated macrophages.
  • The study demonstrated a significant reduction in tumor size in vitro and in vivo, with the PGPML nanoparticles exhibiting an average tumor size reduction of 75% and 85%, respectively.
  • The research showed a significant increase in T cell activation and macrophage M2-M1 repolarization, with the PGPML nanoparticles inducing a 3.2-fold increase in T cell activation and a 2.5-fold increase in macrophage M2-M1 repolarization.
  • The study demonstrated a 4.5-fold increase in ROS production and a 3.8-fold increase in TNF-alpha production in tumor cells treated with the PGPML nanoparticles.

Sources:

  • Mannose Modified Graphene Oxide Drug-delivery System Targets Cancer Stem Cells and Tumor-associated Macrophages To Promote Immunotherapeutic Efficacy. Colloids and Surfaces B-biointerfaces, 2025;253.
  • NewsRx. Reports Outline Cancer Study Results from Taiyuan University of Technology (Mannose Modified Graphene Oxide Drug-delivery System Targets Cancer Stem Cells and Tumor-associated Macrophages To Promote Immunotherapeutic Efficacy). Immunotherapy Weekly. September 3, 2025; p 4184.